WOCKPHARMA Wockhardt Ltd Investments/Divestments Announcement 2024 - Financial Update Wockhardt Ltd reported impressive EBITDA growth of ~74%, revenue growth of 7%, launched new antibiotic, and provided updates on clinical trials..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Wockhardt Ltd